subject_id=OCCAMS/AH/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/071;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/071;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/039;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/039;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/043;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/025;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/024;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/001;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/133;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/040;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/133;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/133;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/040;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/040;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/100;gender=female;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/100;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/100;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/071;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/115;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/025;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/024;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/115;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/039;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/043;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/043;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/115;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/025;gender=female;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/024;gender=female;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=AHM1051;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
